References
- Amino acid metabolism III. In: White A, Handler P, Smith EL, et al, eds. Principles of biochemistry. 7th ed. New York: McGraw-Hill, 1983: 640–2
- L-tryptophan: a “natural” sedative? Med Lett Drugs Ther 1977: 19(26): 108
- Reynolds JE. The extra pharmacopoeia. 29th ed. London: Pharmaceutical Press, 1989: 383–4
- Lahmeyer HW. Tryptophan for insomnia. JAMA 1989: 262(19): 2748
- Wyatt RJ, Engelman K, Kupfer DJ, et al. Effects of L-tryptophan (a natural sedative) on human sleep. Lancet 1970: 2(678): 842–6
- Freese A, Schwartz KJ, During M. Potential neurotoxicity of tryptophan. (Letter) Ann Intern Med 1988: 108(2): 312–3
- Hertzman PA, Blevins WL, Mayer J, et al. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990: 322(13): 869–73
- Eosinophilia-myalgia syndrome: New Mexico. JAMA 1989: 262(22): 3116
- Kilbourne EM, Swygert LA, Philen RM, et al. Interim guidance on the eosinophilia-mvalgia syndrome. Ann Intern Med 1990: 112(2): 85–7
- Silver RM, Heyes MP, Maize JC, et al. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N Engl J Med 1990: 322(13): 874–81
- Analysis of L-tryptophan for the etiology of eosinophilia-myalgia syndrome. JAMA 1990: 264(13): 1656
- Clauw DJ, Nashel DJ, Umhau A, et al. Tryptophan-associated eosinophilic connectivetissue disease: a new clinical entity? JAMA 1990: 263(11): 1502–6
- Flannery MT, Wallach PM, Espinoza LR, et al. A case of the eosinophilia-myalgia syndrome associated with use of an L-tryptophan product. Ann Intern Med 1990: 112(4): 300–1